Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 studyAdele K. Fielding, Anthony H. Goldstone, Susan Richards et al.|Blood|2006Cited by 843
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)Anthony H. Goldstone, Jacob M. Rowe, Susan Richards et al.|Blood|2007Cited by 782
Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow TransplantationNavneet S. Majhail, C. Frederick LeMaistre, Stephanie Farnia et al.|Biology of Blood and Marrow Transplantation|2015Cited by 409
Second Solid Cancers after Allogeneic Hematopoietic Cell Transplantation Using Reduced-Intensity ConditioningOlle Ringdén, Navneet S. Majhail, Ruta Brazauskas et al.|Biology of Blood and Marrow Transplantation|2014Cited by 67
Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic SyndromesChristine Duncan, Mohamed L. Sorror, Navneet S. Majhail et al.|Biology of Blood and Marrow Transplantation|2014Cited by 64